Raymond James Downgrades Sierra Bancorp to Market Perform

 First study of AllocetraTM in thumb osteoarthritis, a debilitating disease that affects millions of people in the U.S., and has no FDA-approved therapy Third study of AllocetraTM in osteoarthritis, following